| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Fatty Liver | D005234 | 48 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Nervous System Diseases | D009422 | 37 associated lipids |
| Movement Disorders | D009069 | 3 associated lipids |
| Fever | D005334 | 35 associated lipids |
| Catalepsy | D002375 | 30 associated lipids |
| Death, Sudden | D003645 | 12 associated lipids |
| Tremor | D014202 | 15 associated lipids |
Decanoic acid
Decanoic acid is a lipid of Fatty Acyls (FA) class. Decanoic acid is associated with abnormalities such as Hashimoto Disease, Perisylvian syndrome, Parasitic Diseases, Acute myocardial infarction and Myocardial Infarction. The involved functions are known as Cell Differentiation process, Inflammation, Process, Subtraction process and Pressure- physical agent. Decanoic acid often locates in Epithelium, Tissue membrane, Body tissue, Membrane and Organelles. The associated genes with Decanoic acid are Genome, FATE1 gene, HTR3A wt Allele, FFAR1 gene and O3FAR1 gene. The related lipids are Membrane Lipids, Fatty Acids, Micelles, Stearic acid and rac-glycerol 1-monodecanoate.
Cross Reference
Introduction
To understand associated biological information of Decanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Decanoic acid?
Decanoic acid is suspected in Hashimoto Disease, Perisylvian syndrome, Parasitic Diseases, Acute myocardial infarction, Myocardial Infarction and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Decanoic acid
PubChem Associated disorders and diseases
What pathways are associated with Decanoic acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Decanoic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Decanoic acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Am. J. Physiol. Gastrointest. Liver Physiol. (4)
- J. Biol. Chem. (3)
- Biochim. Biophys. Acta (1)
- Others (12)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Decanoic acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Decanoic acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Decanoic acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Decanoic acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Decanoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Siris SG et al. | Comparison of 6- with 9-week trials of adjunctive imipramine in postpsychotic depression. | 1989 Nov-Dec | Compr Psychiatry | pmid:2582754 |
| McEvoy JP and Freter S | The dose-response relationship for memory impairment by anticholinergic drugs. | 1989 Mar-Apr | Compr Psychiatry | pmid:2920548 |
| Pérez C and Stier Rosner SE | [Haloperidol decanoate: results of a 6-month open trial in paranoid schizophrenia]. | 1989 Jul-Dec | Acta Psiquiatr Psicol Am Lat | pmid:2576990 |
| Dean HG et al. | HPLC analysis of brain and plasma for octanoic and decanoic acids. | 1989 | Clin. Chem. | pmid:2776322 |
| Marder SR et al. | Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine. | 1989 | Psychopharmacol Bull | pmid:2626520 |
| Yamamoto T and Ueki S | Behavioral and electroencephalographic effects of a depot type neuroleptic fluphenazine decanoate, in rats. | 1989 | J. Pharmacobio-dyn. | pmid:2632765 |
| Zbytovský J and Zapletálek M | Longitudinal study of the effect, tolerance and undesired side effects of injection haloperidol decanoate applied in different psychiatric indications. | 1989 | Act Nerv Super (Praha) | pmid:2638106 |
| Levin ED and Gunne LM | Chronic neuroleptic effects on spatial reversal learning in monkeys. | 1989 | Psychopharmacology (Berl.) | pmid:2567030 |
| Stoessl AJ et al. | Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists. | 1989 | Psychopharmacology (Berl.) | pmid:2568657 |
| Chouinard G et al. | A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia. | 1989 | J Clin Psychopharmacol | pmid:2570086 |
| Alda M et al. | Pharmacokinetic properties of haloperidol decanoate. | 1989 | Act Nerv Super (Praha) | pmid:2571223 |
| Zapletálek M and Zbytovský J | Haloperidol decanoate in the treatment of schizophrenia. | 1989 | Act Nerv Super (Praha) | pmid:2571224 |
| Zbytovský J and Zapletálek M | Haloperidol decanoate in the treatment of sexual deviations. | 1989 | Act Nerv Super (Praha) | pmid:2571225 |
| Leong OK et al. | A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia. | 1989 | Singapore Med J | pmid:2575796 |
| Neehall J | Tardive dyskinesia in outpatients on depot phenothiazine. | 1989 | West Indian Med J | pmid:2576166 |
| Odle J et al. | Utilization of medium-chain triglycerides by neonatal piglets: II. Effects of even- and odd-chain triglyceride consumption over the first 2 days of life on blood metabolites and urinary nitrogen excretion. | 1989 | J. Anim. Sci. | pmid:2613580 |
| Larsen NE and Hansen LB | Prediction of the optimal perphenazine decanoate dose based on blood samples drawn within the first three weeks. | 1989 | Ther Drug Monit | pmid:2595744 |
| Inderbitzin LB et al. | Fluphenazine decanoate: a clinical problem? | 1989 | Am J Psychiatry | pmid:2563210 |
| Kong DS and Yeo SH | An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia. | 1989 | Pharmatherapeutica | pmid:2687894 |
| Froemming JS et al. | Pharmacokinetics of haloperidol. | 1989 | Clin Pharmacokinet | pmid:2689040 |
| Weinstein D et al. | Delayed appearance of facial tics following chronic fluphenazine administration to guinea pigs. | 1989 | Pharmacol. Biochem. Behav. | pmid:2798529 |
| Brotman AW and McCormick S | Converting doses of fluphenazine decanoate to oral equivalent. | 1989 | Am J Psychiatry | pmid:2729448 |
| Drtil J | Treatment of patients dependent on tobacco with fluphenazine decanoate. | 1989 | Act Nerv Super (Praha) | pmid:2800941 |
| Nasser J and Thomas B | Haloperidol decanoate. | 1989 | Aust N Z J Psychiatry | pmid:2803140 |
| Kauffman VG et al. | Extrapyramidal side effects caused by fluphenazine decanoate in a horse. | 1989 | J. Am. Vet. Med. Assoc. | pmid:2808106 |
| Bryant ML et al. | Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. | 1989 | Proc. Natl. Acad. Sci. U.S.A. | pmid:2813417 |
| Siris SG et al. | Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression. | 1989 | Am J Psychiatry | pmid:2817126 |
| Jahnke LL and Diggs K | Evidence for the synthesis of the multi-positional isomers of monounsaturated fatty acid in Methylococcus capsusatus by the anaerobic pathway. | 1989 | FEMS Microbiol. Lett. | pmid:11542184 |
| Glazer WM | Fluphenazine decanoate. Its steady-state pharmacologic profile and relationship to tardive dyskinesia. | 1988 Nov-Dec | Schizophr. Res. | pmid:3154530 |
| Siris SG et al. | Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression. | 1988 Jan-Feb | Schizophr. Res. | pmid:3154504 |
| Siris SG et al. | Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations. | 1988 | Clin. Chem. | pmid:3286051 |
| Soni SD et al. | Plasma levels of fluphenazine decanoate. Effects of site of injection, massage and muscle activity. | 1988 | Br J Psychiatry | pmid:3250675 |
| Curbelo HM et al. | Effects of anabolic-androgenic steroids on hair waves in castrated mice. | 1988 | Acta Physiol Pharmacol Latinoam | pmid:3273624 |
| Khachik F and Beecher GR | Separation of carotenol fatty acid esters by high-performance liquid chromatography. | 1988 | J. Chromatogr. | pmid:3235576 |
| Duran M et al. | Cis-4-decenoic acid in plasma: a characteristic metabolite in medium-chain acyl-CoA dehydrogenase deficiency. | 1988 | Clin. Chem. | pmid:3349606 |
| Tomita M et al. | Enhancement of colonic drug absorption by the transcellular permeation route. | 1988 | Pharm. Res. | pmid:3247289 |
| Legras A et al. | Protracted neuroleptic malignant syndrome complicating long-acting neuroleptic administration. | 1988 | Am. J. Med. | pmid:2904226 |
| Viala A et al. | Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate. | 1988 | Psychopharmacology (Berl.) | pmid:2895936 |
| Hemstrom CA et al. | Haloperidol decanoate: a depot antipsychotic. | 1988 | Drug Intell Clin Pharm | pmid:2897276 |
| Clarke DJ and Ford R | Treatment of refractory Tourette syndrome with haloperidol decanoate. | 1988 | Acta Psychiatr Scand | pmid:3164570 |
| Rueda-Vasquez E | Outcome of treatment with haloperidol decanoate in a patient with schizophrenia, chronic undifferentiated type, and end stage renal disease. | 1988 | Mil Med | pmid:2907928 |
| Boyson SJ et al. | Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum. | 1988 | J. Pharmacol. Exp. Ther. | pmid:2908050 |
| Rosengarten H et al. | Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements. | 1988 | Adv. Exp. Med. Biol. | pmid:2976249 |
| Asarnow RF et al. | Differential effect of low and conventional doses of fluphenazine on schizophrenic outpatients with good or poor information-processing abilities. | 1988 | Arch. Gen. Psychiatry | pmid:3046554 |
| Siris SG et al. | Postpsychotic depression and negative symptoms: an investigation of syndromal overlap. | 1988 | Am J Psychiatry | pmid:3057924 |
| Nagi MN et al. | Dual action of 2-decynoyl coenzyme A: inhibitor of hepatic mitochondrial trans-2-enoyl coenzyme A reductase and peroxisomal bifunctional protein and substrate for the mitochondrial beta-oxidation system. | 1988 | Arch. Biochem. Biophys. | pmid:3058034 |
| Kitamura T et al. | Plasma levels of fluphenazine and prolactin in psychiatric patients. | 1988 | Eur Arch Psychiatry Neurol Sci | pmid:3181218 |
| Siris SG and Strahan A | Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression. | 1988 | J Clin Psychiatry | pmid:3182733 |
| Jefferson JW | Haldol decanoate and thyroid disease. | 1988 | J Clin Psychiatry | pmid:3182741 |
| Lo ES et al. | A highly sensitive and specific radioimmunoassay for quantitation of plasma fluphenazine. | 1988 | J Pharm Sci | pmid:3373431 |
| Van Hoogdalem EJ et al. | Rectal absorption enhancement of rate-controlled delivered ampicillin sodium by sodium decanoate in conscious rats. | 1988 | Pharm Weekbl Sci | pmid:3393421 |
| Hogarty GE et al. | Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Results of a two-year controlled study. | 1988 | Arch. Gen. Psychiatry | pmid:3415422 |
| Yadalam KG and Simpson GM | Changing from oral to depot fluphenazine. | 1988 | J Clin Psychiatry | pmid:3417620 |
| Siris SG et al. | Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate. | 1988 | J Clin Psychiatry | pmid:3338977 |
| Gitlin MJ et al. | Persistence of fluphenazine in plasma after decanoate withdrawal. | 1988 | J Clin Psychopharmacol | pmid:3351000 |
| Nuñez de Kairuz MS et al. | Fatty acid dependent hydrogen peroxide production in Lactobacillus. | 1988 | Biochem. Biophys. Res. Commun. | pmid:3358755 |
| Levron JC and Ropert R | [Clinical pharmacokinetics of haloperidol decanoate. Comparison with other prolonged-action neuroleptics]. | 1987 Mar-Apr | Encephale | pmid:2885172 |
| Matsunaga Y et al. | Absorption of intramuscularly administered [14C]haloperidol decanoate in rats. | 1987 Jul-Sep | Eur J Drug Metab Pharmacokinet | pmid:3436339 |
| Oh-e Y et al. | Hydrolysis of haloperidol decanoate in vitro by cultured cells. | 1987 Jul-Sep | Eur J Drug Metab Pharmacokinet | pmid:3436340 |
| Marder SR et al. | Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome. | 1987 | Arch. Gen. Psychiatry | pmid:3555385 |
| Siris SG et al. | Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial. | 1987 | Arch. Gen. Psychiatry | pmid:3555386 |
| Honoré B | Protein binding studies with radiolabeled compounds containing radiochemical impurities. Equilibrium dialysis versus dialysis rate determination. | 1987 | Anal. Biochem. | pmid:3605598 |
| Nambu K et al. | Enzymatic hydrolysis of haloperidol decanoate and its inhibition by proteins. | 1987 | Biochem. Pharmacol. | pmid:3593395 |
| Sandberg L and Siris SG | "Panic disorder" in schizophrenia. | 1987 | J. Nerv. Ment. Dis. | pmid:3655772 |
| Hietala J et al. | Alterations in peripheral and central dopamine receptor sensitivity after subchronic treatment with fluphenazine and sulpiride. | 1987 | Pharmacol. Toxicol. | pmid:3628181 |
| Bloom DM et al. | Verapamil in refractory schizophrenia: a case report. | 1987 | Prog. Neuropsychopharmacol. Biol. Psychiatry | pmid:3628827 |
| Ellerman LA | [Open clinical trial with haloperidol decanoate in patients with psychotic disorders]. | 1987 | Acta Psiquiatr Psicol Am Lat | pmid:3321918 |
| McKane JP et al. | Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients. | 1987 | Br J Psychiatry | pmid:3322467 |
| Cavrini V et al. | Analysis of nandrolone esters in oily injections by reversed-phase high-performance liquid chromatography. | 1987 | J Pharm Biomed Anal | pmid:16867543 |
| Altamura AC et al. | Fluphenazine decanoate in acute and maintenance therapy of schizophrenia. | 1987 | Prog. Neuropsychopharmacol. Biol. Psychiatry | pmid:3122268 |
| Midha KK et al. | The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate. | 1987 | Psychopharmacology (Berl.) | pmid:3124166 |
| Turns DM et al. | Depot neuroleptics for acutely psychotic patients. | 1987 | Am J Psychiatry | pmid:2886066 |
| Levy AD et al. | Neuroleptic-induced oral movements in rats: methodological issues. | 1987 | Life Sci. | pmid:2887997 |
| Mithani S et al. | Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities. | 1987 | Psychopharmacology (Berl.) | pmid:2888156 |
| Brambilla F et al. | Effects of neuroleptic treatments on peripheral opioid secretion. | 1987 | Neuropsychobiology | pmid:2897644 |
| Akiyama K et al. | Effect of chronic administration of haloperidol (intermittently) and haloperidol-decanoate (continuously) on D2 dopamine and muscarinic cholinergic receptors and on carbachol-stimulated phosphoinositide hydrolysis in the rat striatum. | 1987 | Jpn. J. Psychiatry Neurol. | pmid:2830427 |
| Norman TR et al. | Plasma prolactin and fluphenazine concentrations in patients receiving fluphenazine decanoate: stability over injection intervals. | 1987 | Int Clin Psychopharmacol | pmid:3693869 |
| Turbott J et al. | Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome. | 1987 | Aust N Z J Psychiatry | pmid:3435373 |
| Lagomarsino AJ | [Haloperidol decanoate in psychotic patients]. | 1987 | Acta Psiquiatr Psicol Am Lat | pmid:3442249 |
| Elliott JR et al. | Local anesthetic action of carboxylic esters: evidence for the significance of molecular volume and for the number of sites involved. | 1987 | J. Membr. Biol. | pmid:3573032 |
| Glazer WM et al. | Injection site leakage of depot neuroleptics: intramuscular versus subcutaneous injection. | 1987 | J Clin Psychiatry | pmid:3584079 |
| Gelenberg AJ | Significant greater loss of medication from the injection site when fluphenazine (Prolixin) decanoate was injected intramuscularly as contrasted with subcutaneously. | 1987 | J Clin Psychiatry | pmid:3667545 |
| Vamecq J and Draye JP | Interactions between the omega- and beta-oxidations of fatty acids. | 1987 | J. Biochem. | pmid:3667564 |
| Nayak RK et al. | The bioavailability and pharmacokinetics of oral and depot intramuscular haloperidol in schizophrenic patients. | 1987 | J Clin Pharmacol | pmid:3680566 |
| Shimizu T et al. | Chemical properties of lipopolysaccharide-like substance (LLS) extracted from Leptospira interrogans serovar canicola strain Moulton. | 1987 | Microbiol. Immunol. | pmid:3683216 |
| Beresford R and Ward A | Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis. | 1987 | Drugs | pmid:3545764 |
| Warren JA | Haloperidol dosage form hazard. | 1986 Jul-Aug | Drug Intell Clin Pharm | pmid:3743422 |
| Bogliolo C | [Use of fluphenazine decanoate in psychiatric therapy. Multicenter study in 1095 patients preselected for long-acting neuroleptic treatment]. | 1986 Jan-Mar | Minerva Psichiatr | pmid:3713474 |
| Stinus L et al. | Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens. | 1986 | Biol. Psychiatry | pmid:2867790 |
| Kolakowska T et al. | Tardive dyskinesia in schizophrenics under 60 years of age. | 1986 | Biol. Psychiatry | pmid:2868762 |
| Kane JM | Dosage strategies with long-acting injectable neuroleptics, including haloperidol decanoate. | 1986 | J Clin Psychopharmacol | pmid:2870088 |
| Marder SR | Depot neuroleptics: side effects and safety. | 1986 | J Clin Psychopharmacol | pmid:2870089 |
| Van Putten T and Marder SR | Low-dose treatment strategies. | 1986 | J Clin Psychiatry | pmid:2871010 |
| De Cuyper H et al. | Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration. | 1986 | Br J Psychiatry | pmid:2877701 |
| Bamrah JS et al. | Interactions between procyclidine and neuroleptic drugs. Some pharmacological and clinical aspects. | 1986 | Br J Psychiatry | pmid:2878700 |
| Marder SR et al. | Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate. | 1986 | Psychopharmacology (Berl.) | pmid:3085136 |
| Curson DA et al. | Does short term placebo treatment of chronic schizophrenia produce long term harm? | 1986 | Br Med J (Clin Res Ed) | pmid:3094627 |
| Ruelius HW et al. | Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin. | 1986 | Adv. Exp. Med. Biol. | pmid:3766273 |
| Sills MA et al. | Role of octanoic and decanoic acids in the control of seizures. | 1986 | Arch. Dis. Child. | pmid:3492967 |
| Vasavan Nair NP et al. | A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence. | 1986 | J Clin Psychopharmacol | pmid:3514689 |